Comparative Pathogenicity of \u3ci\u3eEscherichia coli\u3c/i\u3e O157 and
Intimin-Negative Non-O157 Shiga Toxin-Producing
\u3ci\u3eE. coli\u3c/i\u3e Strains in Neonatal Pigs by Dean-Nystrom, Evelyn A. et al.
University of Nebraska - Lincoln 
DigitalCommons@University of Nebraska - Lincoln 
Publications from USDA-ARS / UNL Faculty U.S. Department of Agriculture: Agricultural Research Service, Lincoln, Nebraska 
11-2003 
Comparative Pathogenicity of Escherichia coli O157 and Intimin-
Negative Non-O157 Shiga Toxin-Producing E. coli Strains in 
Neonatal Pigs 
Evelyn A. Dean-Nystrom 
Pre-Harvest Food Safety and Enteric Diseases Research Unit, evelyn.nystrom@ars.usda.gov 
Angela R. Melton-Celsa 
F. Edward Hebert School of Medicine, angela.melton-celsa@usuhs.edu 
Joachim F. L. Pohlenz 
School of Veterinary Medicine, Hannover, Germany 
Harley W. Moon 
Iowa State University 
Alison D. O’Brien 
F. Edward Hebert School of Medicine 
Follow this and additional works at: https://digitalcommons.unl.edu/usdaarsfacpub 
 Part of the Agricultural Science Commons 
Dean-Nystrom, Evelyn A.; Melton-Celsa, Angela R.; Pohlenz, Joachim F. L.; Moon, Harley W.; and O’Brien, 
Alison D., "Comparative Pathogenicity of Escherichia coli O157 and Intimin-Negative Non-O157 Shiga 
Toxin-Producing E. coli Strains in Neonatal Pigs" (2003). Publications from USDA-ARS / UNL Faculty. 932. 
https://digitalcommons.unl.edu/usdaarsfacpub/932 
This Article is brought to you for free and open access by the U.S. Department of Agriculture: Agricultural Research 
Service, Lincoln, Nebraska at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in 
Publications from USDA-ARS / UNL Faculty by an authorized administrator of DigitalCommons@University of 
Nebraska - Lincoln. 
INFECTION AND IMMUNITY, Nov. 2003, p. 6526–6533 Vol. 71, No. 11
0019-9567/03/$08.000 DOI: 10.1128/IAI.71.11.6526–6533.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Comparative Pathogenicity of Escherichia coli O157 and
Intimin-Negative Non-O157 Shiga Toxin-Producing
E. coli Strains in Neonatal Pigs
Evelyn A. Dean-Nystrom,1* Angela R. Melton-Celsa,2 Joachim F. L. Pohlenz,3
Harley W. Moon,4 and Alison D. O’Brien2
Pre-Harvest Food Safety and Enteric Research Unit, National Animal Disease Center, USDA Agricultural Research Service, Ames,
Iowa1; Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences,
F. Edward He´bert School of Medicine, Bethesda, Maryland2; Institute for Pathology, School of
Veterinary Medicine, Hannover, Germany3; and Department of Veterinary Pathology,
Iowa State University, Ames, Iowa4
Received 7 April 2003/Returned for modification 21 May 2003/Accepted 15 July 2003
We compared the pathogenicity of intimin-negative non-O157:H7 Shiga toxin (Stx)-producing Escherichia
coli (STEC) O91:H21 and O104:H21 strains with the pathogenicity of intimin-positive O157:H7 and O157:H
strains in neonatal pigs. We also examined the role of Stx2d-activatable genes and the large hemolysin-
encoding plasmid of O91:H21 strain B2F1 in the pathogenesis of STEC disease in pigs. We found that all E.
coli strains that made wild-type levels of Stx caused systemic illness and histological lesions in the brain and
intestinal crypts, whereas none of the control Stx-negative E. coli strains evoked comparable central nervous
system signs or intestinal lesions. By contrast, the absence of intimin, hemolysin, or motility had little impact
on the overall pathogenesis of systemic disease during STEC infection. The most striking differences between
pigs inoculated with non-O157 STEC strains and pigs inoculated with O157 STEC strains were the absence of
attaching and effacing intestinal lesions in pigs inoculated with non-O157:H7 strains and the apparent
association between the level of Stx2d-activatable toxin produced by an STEC strain and the severity of lesions.
Serotype O157:H7 Shiga toxin (Stx)-producing Escherichia
coli (STEC) strains cause the majority of sporadic and multi-
person outbreaks of bloody diarrhea in the United States (15).
However, non-O157 STEC strains were the source of three
such outbreaks of bloody diarrhea (1) and an apparent cluster
of three cases of hemolytic-uremic syndrome (HUS) (5, 26)
and may be responsible for 20% (2) or even 50% (13) of all
STEC infections. Up to 10% of patients with hemorrhagic
colitis due to infection with an O157 strain develop HUS, a
sequela that includes serious kidney damage. The risk of HUS
for patients infected with non-O157 STEC is not as clear, but
it could be as high as that for patients infected with O157
strains (29).
STEC can be grouped by the array of potential virulence
factors that they express. All STEC strains produce one or
more Stxs. There are two main groups of Stxs (also called
verotoxins), Stx1 and Stx2, which have the same enzymatic
activity and general structure but are not cross-neutralized by
heterologous antisera (34). The Stx2 group contains variants
that include Stx2c (39), Stx2d-activatable (whose toxicity is
increased by elastase from intestinal mucus [31]) (23, 43),
Stx2d-nonactivatable (36), Stx2e (associated with edema dis-
ease in weaned pigs [48]), and Stx2f (isolated from feral pi-
geons and from a child with diarrhea [33, 38]).
A number of STEC strains have the same general constel-
lation of pathogenic factors as the O157:H7 isolates. These
strains not only produce Stxs but also have the capacity to
cause attaching and effacing (A/E) lesions in the intestines of
animals or in tissue culture models (8). A/E lesion formation is
mediated by products of the locus of enterocyte effacement
(LEE) found in enterohemorrhagic E. coli O157 strains and
some non-O157 STEC strains, such as all O26:H11 strains and
most O111:H strains (20). The LEE is also found in entero-
pathogenic E. coli and in some non-E. coli species (27). In-
timin, the product of the eae gene (located in, and sometimes
used as a marker for, the LEE pathogenicity island), is re-
quired for both the adherence of O157:H7 strain 86-24 to
HEp-2 cells and the colonization of neonatal pigs and calves by
strain 86-24 (8, 9, 46). However, the factor(s) responsible for
colonization by non-O157 strains that lack intimin is not as well
established, although a few candidate adhesins have been iden-
tified (10, 35, 41). Most STEC strains harbor a large (90-kb)
hemolysin-encoding plasmid. There is conflicting evidence
about whether this plasmid is required for virulence (19, 21,
47).
Intimin-negative STEC strains that produce the Stx2d-acti-
vatable variant of Stx2 (30) have low 50% lethal doses (LD50s)
(101 to 102 CFU) in a streptomycin-treated CD-1 mouse model
of STEC infection, whereas O157:H7 strains consistently have
LD50s of 10
10 CFU or greater in CD-1 mice (24, 30, 47). One
such Stx2d-activatable variant producer, B2F1, is an O91:H21
strain associated with the development of HUS in a child (18).
The essential role of the Stx2d-activatable variant in the patho-
genesis of B2F1 in streptomycin-treated mice was demon-
strated by the finding that toxin mutants of B2F1 are attenu-
ated in this mouse model (24) and the finding that passive
administration of monoclonal antibodies that recognize Stx2 or
Stx2 variants (e.g., Stx2d-activatable variants) protects mice
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from the otherwise lethal B2F1 infection (43). B2F1 has two
copies of the gene for the Stx2d-activatable variant, one of
which is phage encoded and expressed at low levels (43). An-
other strain that produces an Stx2d-activatable variant is 3024-
94, an O104:H21 strain associated with an outbreak of bloody
diarrhea in Montana (4, 12). This strain appears to contain
only one copy of the gene for the potent Stx2d-activatable toxin
(Melton-Celsa, unpublished observations).
The low oral LD50s of the intimin-negative non-O157 STEC
strains B2F1 and 3024-94 for streptomycin-treated mice (30),
along with the linkage of these strains to human cases of HUS
and hemorrhagic colitis, respectively, led us to hypothesize that
these isolates would be virulent in neonatal pigs. In this study,
we tested this theory by comparing the pathogenicity of these
intimin-negative isolates with that of STEC O157 strains. We
also evaluated the role of each of the copies of the Stx2d-
activatable gene and of the large hemolysin-encoding plasmid
of strain B2F1 in the pathogenesis of STEC disease.
MATERIALS AND METHODS
Bacteriologic strains and inocula. The bacterial strains used in this study are
described in Table 1. All STEC strains used were streptomycin-resistant deriv-
atives of the original clinical isolate. The control E. coli strain, 123, is resistant to
nalidixic acid. Stock inocula were prepared and stored as previously described
(7). The STEC strain B2F1 used in this study has two copies of stx2d-activatable,
which are referred to below as stx2d1-activatable and stx2d2-activatable for clarity. The
plasmid-cured derivative of B2F1 no longer produces detectable hemolytic ac-
tivity (40).
Bacteriologic examination. The numbers of an inoculated strain recovered
from tissues and feces of pigs were determined on sorbitol MacConkey agar
containing 100 g of streptomycin per ml (strain 86-24 and strain E32511/HSC/
L), MacConkey agar containing 100 g of streptomycin per ml (eae-negative
STEC strains), or MacConkey agar containing 20 g of nalidixic acid per ml
(strain 123). Samples from which the inoculated strain were not recovered were
recorded as having 103 CFU/g of tissue. Selected sorbitol-negative isolates
(strains 86-24 and E32511/HSC/L) were tested for O157:H7 antigen by the latex
agglutination assay (7). Selected coliforms were tested for O91 antigen (strain
B2F1 and its derivatives), O104 antigen (strain 3024-94), or O43 antigen (strain
123) by performing a colony blot immunoassay with appropriate O-specific sera
(8).
Histologic studies. Tissues were fixed in neutral buffered 10% formalin for 24
to 48 h, embedded in paraffin, sectioned, and stained with hematoxylin and eosin.
The periodic acid-Schiff reaction was used to detect microvascular damage in the
brain. Samples of colon from selected animals were prepared for electron mi-
croscopy studies (7).
Immunoperoxidase staining with O-specific antibodies. Inoculum-type bacte-
ria in formalin-fixed intestinal tissues were identified by indirect immunoperox-
idase (horseradish peroxidase) staining with goat anti-O157:H7 antibody (7) or
by using rabbit anti-O91, anti-O104, or anti-O43 antibody (E. coli Reference
Center, Pennsylvania State University, University Park, Pa.) as the primary
antibody and biotinylated goat anti-rabbit antibody (Vector Laboratories, Inc.,
Burlingame, Calif.) the as the secondary antibody.
Pathogenicity in neonatal pigs. Sixty-one cesarean-derived, colostrum-de-
prived (CDCD) 8-h-old pigs from seven litters, which had received 20 ml of
normal swine serum intraperitoneally shortly after birth, were inoculated via a
stomach tube with 1010 CFU of the following strains: O157:H7 strain 86-24
(group A; 15 pigs from six litters); O157:H strain E32511/HSC/L (group B; 5
pigs from two litters); O104:H21 strain 3024-94 (group C; 6 pigs from two litters);
O91:H21 strain B2F1 (group D; 9 pigs from five litters); B2F1 (plasmid cured)
(group E; 4 pigs from 2 litters); B2F1stx2d1-activatable::cat, designated B2F1
Stx2d2-activatable (group F; 7 pigs from 4 litters); B2F1stx2d2-activatable::cat,
designated B2F1 Stx2d1-activatable (group G; 7 pigs from four litters); and
control E. coli strain 123 (group H; 8 pigs from five litters). The inoculated
animals were maintained in individual plastic cages and fed a diet consisting of
autoclaved SPF-LAC (Borden, Elgin, Ill.) or Esbilac (Pet Ag, Hampshire, Ill.) as
previously described (7). The pigs were observed every 4 to 8 h for signs of
clinical disease and were euthanized with sodium pentobarbital 31 to 69 h after
inoculation. The pigs were euthanized as soon as central nervous system (CNS)
signs were noted.
At necropsy, sections from the ileum and cecum were collected aseptically and
frozen at 80°C for bacteriological culture. Sections of terminal ileum, cecum,
colon (complete coil to provide several crosscuts in one section), distal colon,
brain (medulla oblongata and brain stem), kidney, and other parenchymal tissues
were collected for histopathologic examination and immunoperoxidase staining
(intestinal tissues only).
Disclaimer. Mention of trade names or commercial products in this article is
solely for the purpose of providing specific information and does not imply
recommendation or endorsement by the U.S. Department of Agriculture.
RESULTS
Clinical signs. CNS signs were the most striking clinical
observations in pigs inoculated with STEC. As shown in Table
2, one or more pigs in all groups except group H (control strain
123) showed CNS signs that ranged from mild (tremors, de-
pression, poor appetite) to severe (seizures, ataxia, recum-
bency, paddling). The CNS signs were severe (e.g., extreme
weakness in rear legs, lateral recumbency, seizures, paddling)
in approximately one-third of the pigs that developed CNS
signs. Most CNS signs appeared between 41 and 50 h postin-
fection (pi), but three pigs (one each in groups A, E, and F)
showed severe CNS signs by 31 to 32 h pi. One other pig in
group F died between observations at 32 and 39 h pi. The CNS
signs were milder and less common in pigs in group G (B2F1
Stx2d1-activatable) than in the other STEC groups. Diarrhea
was uncommon (Table 2) and occurred only in pigs inoculated
TABLE 1. E. coli strains used in this study
Group Strain Serotype eae gene stx genotype Source Reference(s)
A 86–24 O157:H7  stx2 P. Tarr 8, 28
B E32511/HSC/L O157:H  stx2c 17
C 3024–94 O104:H21  stx2d-activatable CDC
a 4
D B2F1 O91:H21 stx2d1-activatable M. Karmali 18
stx2d2-activatable 30
E B2F1 (plasmid cured) O91:H21  stx2d1-activatable A. D. O’Brien 40
stx2d2-activatable
F B2F1 Stx2d2-activatable O91:H21  stx2d1-activatable::cat A. D. O’Brien 43
stx2d2-activatable
G B2F1 Stx2d1-activatable O91:H21  stx2d1-activatable A. D. O’Brien 43
stx2d2-activatable::cat
H 123 (control) O43:H28  NAb 7, 32
a CDC, Centers for Disease Control and Prevention.
b NA, not applicable.
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with STEC belonging to serotype O157 or O104 (groups A, B,
and C). Thirteen STEC-inoculated pigs that did not have di-
arrhea had liquid feces in the rectum at necropsy. None of the
control pigs (group H) had diarrhea or liquid contents in the
rectum.
Macroscopic lesions. Colonic edema (22 pigs) and subcuta-
neous edema (19 pigs) were seen in all STEC groups except
group G (B2F1 Stx2d1-activatable), but they occurred in only
one of the six pigs in group C (3024-94). An increase in clear
fluid was noted in the meninges of some O157-infected pigs
(four pigs in group A and one pig in group B) and O91-
infected pigs (four pigs in group E and one pig in group F), and
this was interpreted to be edema. Gall bladder edema was seen
in one pig each in groups A and E. No macroscopic lesions
were seen in any of the controls (group H).
Bacterial counts. The mean numbers of inoculum-type bac-
teria recovered from the ileum and cecum of pigs in each
inoculation group are shown in Table 2. Groups A (86-24) and
G (B2F1 Stx2d1-activatable) had significantly higher levels of
inoculum-type bacteria in the ileum than the control group
had, but the bacterial counts for the other STEC groups were
similar to those for the control group. All groups had 107
CFU of inoculum-type bacteria/g of cecal tissue. STEC groups
A, D, E, F, and G had significantly higher numbers of inocu-
lum-type bacteria in the cecum than the controls (group H)
had.
Microscopic lesions. Histologic lesions were frequently
found in brain and intestinal tissues and sometimes were also
found in kidney tissues of pigs inoculated with STEC but not in
any of the control pigs. The findings for specific anatomical
sites were as follows.
(i) Brain. Lesions were seen in pigs in all groups that were
infected with STEC except group G (B2F1 Stx2d1-activat-
able). No brain lesions were seen in any of the control pigs
(group H). The lesions in group C pigs (3024-94) were subtler
than those in the pigs belonging to the other groups (Table 2).
Perivascular edema and perivascular accumulations of protein
droplets, which stained positive with periodic acid-Schiff stain,
were seen around arterioles, capillaries, and venules in sections
of brain from affected animals. These lesions resembled those
which were described previously for CDCD and suckling pigs
experimentally infected with O157:H7 strain 86-24 (the strain
used for group A in this experiment) (6) but were less severe
than those in suckling piglets.
(ii) Intestine. Irregular layers of E. coli control strain 123
were identified with the O43 antiserum on stained mucosal
surfaces of colonic and cecal tissues from all pigs inoculated
with this control strain. Seven of the eight control pigs had no
morphological lesions in any of the intestinal sites sampled, but
mild to moderate edema and mild to moderate infiltration of
mononuclear cells were observed in sections of the cecum and
colon from one control pig.
In contrast, histologic lesions were evident in the intestines
of all pigs inoculated with an STEC strain. Such lesions were
more common in the cecum and colon than in the ileum. The
type (described below) and distribution of these lesions varied
with the inoculum strain (Table 3). Within inoculum groups,
the degree and intensity of lesions differed from animal to
animal and with the duration of exposure. Intestinal lesions
were seen as early as 31 h pi but were more extensive and more
pronounced in pigs necropsied at later times after inoculation.
Inoculum-type bacteria, identified by immunoperoxidase
staining with appropriate O-specific antiserum, were present in
the lumen and were adherent to mucosal surfaces in cecal and
colonic sections from pigs in all groups. Inoculum-type bacteria
were less frequently seen in the ileum and, when found, were
more often associated with the follicular associated epithelium
(FAE) of the domes than with other epithelial surfaces and
were sometimes associated with FAE cells sloughing off from
the domes.
A/E lesions were found only in pigs inoculated with an O157
strain (groups A and B). These lesions occurred predominantly
TABLE 2. Results for neonatal CDCD pigs after inoculation with STEC or control E. coli
Bacteria and
Serotype Group Inoculum bacteria
Duration
(h)
No. of pigs
tested
No. of pigs with:
Bacterial counts
(log10 CFU/g of
tissue) in:
Diarrhea CNS signs CNS lesionsa Adherentbacteriab Ileum Cecum
STEC
O157 A 86–24 32–49 15 3 12 8 15c 7.6d 8.3
B E32511/HSC/L 46–69 5 2 2 5 5c 6.8 7.1
O104 C 3024–94 42–48 6 2 3 5 6 6.5 7.0
O91 D B2F1 41–50 9 0 5 5 9 6.1 8.2
E B2F1 (plasmid cured) 31–44 4 0 4 2 4 6.1 8.6
F B2F1Stx2d2-
activatable
32–46 7e 0 4e 1 6e 6.4e 8.2e
G B2F1Stx2d1-
activatable
43–47 7 0 1 0 7 7.7 8.3
Control
O43 H 123 41–68 8 0 0 0 8 6.7 7.5
a Medulla oblongata-brain stem sections from all pigs were investigated.
b Adherent inoculum bacteria were identified by immunoperoxidase staining with appropriate O-specific antisera as described in Materials and Methods.
c A/E bacteria stained with anti-E. coli O157:H7 antibody by immunoperoxidase staining.
d Mean values. For each site, mean STEC strain counts were compared with mean control strain counts by using the two-sample t test and a significance level of 0.05.
Bacterial counts that differed significantly from control counts are indicated by boldface type.
e No clinical, bacteriogical, or histological data were obtained for one pig that was found dead at 39 h pi.
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in the large intestine and contained O157 bacteria (Fig. 1A
and B). In pigs inoculated with a non-O157 STEC strain
(groups C to G), inoculum-type bacteria were found closely
adherent to colonic and cecal surfaces (Fig. 1C and D). Bac-
terial adherence was associated with irregular vacuolated cells
that contained fine to coarse droplets (Fig. 1A and C).
Histologic lesions were seen in crypts of cecal and colonic
tissues from all pigs inoculated with an STEC strain. No his-
tologic lesions were seen in colonic tissues from any of the
control pigs, but irregular goblet cells (see below) were seen in
cecal tissues from four of eight control pigs. The type and
distribution of intestinal lesions varied with the inoculum
FIG. 1. (A and C) Horseradish peroxidase-stained sections of colon from a neonatal pig necropsied 49 h after inoculation with STEC O157:H7
strain 86-24 (A) or from a pig necropsied 41 h after inoculation with strain B2F1 (C), showing typical immunostained colonies of O157:H7 A/E
bacteria (A) and adherent O91 bacteria (C) on the mucosal surface. (B and D) Electron micrographs showing intimately attached bacteria and
effaced microvilli in the cecum from a pig necropsied 18 h after inoculation with strain 86-24 (B) (magnification, approximately 6,000) and
adherent bacteria and intact villi on the surface of absorptive epithelial cells in the colon from a pig necropsied 43 h after inoculation with strain
B2F1 (D) (magnification, approximately 3,500).
TABLE 3. Intestinal crypt lesions in neonatal CDCD pigs 31 to 69 h after inoculation with STEC or control E. coli
Group Inoculum bacteria No. of pigs
Proportion of pigs witha:
Irregular goblet cellsb Shift of goblet cellsb Crypt activationb
Cecum Colon Cecum Colon Cecum Colon
A 86–24 15   c  0 
B E32511/HSC/L 5     0 0
C 3024–94 6   0 0  
D B2F1 9   0   0
E B2F1 (plasmid cured) 4     0 0
F B2F1 Stx2d2-activatable 6     0 0
G B2F1 Stx2d1-activatable 7   0 0  
H 123 (control) 8  0 0 0 0 0
a , lesions in 100% of the pigs; , lesions in 50 to 70% of the pigs; , lesions in 20% of the pigs; 0, no lesions in any of the pigs.
b The three types of lesions observed in cecal and colonic crypts of STEC-infected pigs are described in the text.
c Cecum morphological data were available for 9 of the 15 pigs in this group.
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strain. We grouped the kinds of lesions observed in the crypts
of the cecum and colon of STEC-infected pigs into three cat-
egories (Table 3 and Fig. 2). Definitions of these three cate-
gories are given below.
(a) Category 1: irregular goblet cells. Category 1 included
irregularly shaped and distributed goblet cells that were often
extensively dilated. These types of cells were seen in crypts of
colonic samples from all pigs in all STEC groups (Fig. 2B) and
in cecal samples from all but two pigs in the STEC groups (they
were not seen in two pigs in group C). Irregular goblet cells
were not seen in colonic samples from any of the control pigs
but were seen in cecal tissues from four of the eight pigs in the
control group.
(b) Category 2: shift of goblet cells. In category 2 (Fig. 2B),
goblet cells in the base of crypts were replaced by immature
cells that stained dark blue with hematoxylin and eosin and
contained large nuclei. Goblet cells in mid-crypt areas were
irregularly distributed. There was mild to moderate mononu-
clear infiltration of the lamina propria, and in some areas there
was an increase in eosinophils and occasional intraepithelial
cells. Neutrophils were a rare component of the infiltrating
cells. As shown in Table 2, a shift of goblet cells was seen in
cecal and colonic tissues from pigs in groups A and B (O157
strains) and groups E and F [B2F1 (plasmid cured) and B2F1
Stx2d2-activatable] and in colonic tissues but not cecal tissues
from pigs in group D (B2F1). This shift was not seen in groups
C, G, and H (3024-94, B2F1 Stx2d1-activatable, and control
strains, respectively).
Category 3: crypt activation. In category 3 (Fig. 2C), some
goblet cells in mid-crypt areas were extremely dilated and
irregular, and accumulations of mucus and bulging mucus
droplets were oriented towards the lumen. Several crypts were
dilated, and there was mucus streaming out of crypt openings.
Crypts contained intensely stained immature cells. A few neu-
trophils were seen infiltrating the lamina propria in crosscuts of
colonic sections. Crypt activation was seen at all sites at which
a shift of goblet cells was not seen (i.e., in cecal sections from
pigs in groups C, D, and G and in colonic sections from pigs in
groups C and G). Crypt activation was not seen in colonic
samples in which a shift of goblet cells was seen (groups B, D,
F, and G).
(iii) Kidney. Focal tubular necrosis and vascular damage
were noted in some of the pigs inoculated with STEC (groups
A, B, C, E, and G) but not in any of the controls (group H).
Electron microscopic and morphometric investigations to fur-
ther characterize these lesions are in progress.
DISCUSSION
Several conclusions about the pathogenesis of STEC in the
neonatal pig model can be derived from the observations made
in this study. First, intimin is not required for the pathogenicity
of non-O157 STEC in CDCD pigs. Systemic (apparently Stx-
mediated) disease was evident in all groups of animals inocu-
lated with STEC whether the isolate had intimin or not. The
results for strain B2F1 obtained in this study differ from the
previous finding that B2F1, like an eae mutant of O157:H7
strain 86-24, is not pathogenic for CDCD pigs (8). This dis-
crepancy can be explained by differences in the duration of the
experiments. Pigs in the previous study were necropsied 18 h
after they were inoculated with strain B2F1; clinical CNS signs
in the present study appeared between 31 and 50 h after inoc-
ulation.
The presence of CNS damage in all groups of pigs inocu-
FIG. 2. Hemotoxylin- and eosin-stained sections of the large intes-
tine from neonatal pigs. (A) Normal distribution of goblet cells in
crypts of the cecum (circled) from a pig necropsied 48 h after inocu-
lation with E. coli strain 123 (control). (B) Shift of goblet cells in the
colon of a pig 31 h after inoculation with strain B2F1 (plasmid cured).
Crypts were irregular and contained immature crypt cells that stained
dark blue and irregularly distributed goblet cells with a reduced mucus
content (circled). (C) Crypt activation in the cecum from a pig nec-
ropsied 46 h after inoculation with B2F1. Dilated crypts contained
intensely stained immature cells and ballooning goblet cells with bulg-
ing mucus droplets oriented towards the lumen. Note the mucus
streaming out of crypt openings (circled).
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lated with STEC strains strongly suggests that Stx was translo-
cated across the intestinal mucosa whether the strain colonized
the mucosa by A/E-mediated mechanisms or not. However,
STEC strains such as B2F1 and 3024-94 that do not cause A/E
lesions may deliver toxin in a different way than STEC strains
that produce the products of the LEE. The presence of large
numbers of B2F1 and 3024-94 cells in the large intestine is
consistent with the hypothesis that toxin is absorbed through
the mucus and the intestinal epithelial barrier. Furthermore,
the observation that inoculum bacteria covered the FAE cells
of ileal domes in two of the animals suggests that penetration
or entry of toxin might begin in the lower small intestine.
A second conclusion is that STEC-induced mucosal damage
is not dependent on intimin. Mucosal lesions were seen in the
large intestines of all pigs inoculated with either eae or eae
STEC strains. These lesions occurred both in cells on the
surface of the intestine and in crypts in the cecum and colon.
A similar absence of goblet cells and discharge of mucus has
been seen in STEC-inoculated ligated colonic loops in calves
(37). The presence of STEC-induced changes in porcine intes-
tinal mucus suggests that porcine mucus, like human mucus
and mouse mucus (30), may activate Stx2d-activatable variants.
Indeed, preliminary studies suggested that porcine mucus did
activate Stx2d2-activatable variants (data not shown). The ob-
servation that there were STEC-induced changes in mucus,
mucus release, and crypt architecture in the porcine cecum and
colon in these short-term experiments suggests that there
should be further investigation to ascertain the importance of
mucus, crypt cells, and potential early damage of the intestinal
barrier in STEC-mediated disease.
The type of crypt lesions which we saw in the piglets inoc-
ulated with STEC strains resembled those described for mice
infected with LEE-positive Citrobacter rodentium (25). Perhaps
the lesions that were seen in pigs 31 to 69 h after STEC
inoculation were a very early phase of a more severe hyper-
plasia like that which occurs in mice 2 to 3 weeks after they are
inoculated with C. rodentium. Because there are homologous
virulence factors in the LEE pathogenicity islands of C. roden-
tium and LEE-positive STEC, it is possible that these organ-
isms use similar mechanisms to induce colonic lesions in mice
and piglets. Our observation that intimin-negative STEC
strains produced similar colonic lesions in piglets indicates that
factors other than LEE-encoded proteins induce development
of these lesions.
A third conclusion is that classic inflammatory responses are
not common in early STEC disease in CDCD pigs. Inflamma-
tory cells were rarely seen in any of the tissue sections from
STEC-inoculated animals. However, it is possible that the
damage to the mucus and the crypts observed in these exper-
iments in fact reflected very early events in an inflammatory
response. To address this question, the levels of inflammatory
mediators early in infection need to be determined.
A fourth conclusion is that nonmotile STEC O157:H strains,
like O157:H7 strains that are motile, can cause disease in
neonatal pigs. The O157:H strain E32511/HSC/L (eae stx2c
)
colonized neonatal pigs and produced disease and lesions that
were indistinguishable from those produced by STEC
O157:H7 strain 86-24.
A fifth conclusion is that the large plasmid of strain B2F1
does not appear to contain genes that are required for the
development of STEC disease in CDCD pigs. All four of the
piglets inoculated with the plasmid-cured derivative of strain
B2F1 were colonized, displayed signs of CNS disease, and had
CNS and intestinal lesions that were indistinguishable from
those caused by strain B2F1.
A sixth conclusion is that all of the types of Stx2 produced by
the strains used in this study cause similar systemic disease and
CNS lesions in neonatal CDCD pigs. More than one-half of
the pigs inoculated with an STEC strain developed CNS signs
and had histologic lesions in the brain (Table 2). Vascular
lesions in the brains and intestines were similar in pigs inocu-
lated with STEC strains that produced Stx2, Stx2c, or Stx2d-
activatable toxin. These lesions resembled those previously
described for gnotobiotic pigs (14, 45), CDCD pigs (8), and
suckling pigs (6) and early stages of cerebrospinal angiopathy
lesions in weaned pigs with edema disease (3, 22). Approxi-
mately one-third of the STEC-inoculated pigs in this study had
tubular and vascular lesions in the kidneys that were similar to,
but more subtle than, those observed in gnotobiotic pigs at 3 to
33 days after inoculation with STEC (16). Electron micro-
scopic and morphometric investigations to characterize these
lesions are ongoing.
A final conclusion is that different types of Stx2 cause dif-
ferent types of lesions. In spite of the similarities of the findings
for the STEC-challenged animals, there were inoculum-asso-
ciated differences in the types and distribution of intestinal
lesions (Table 3). For example, whereas intimin-positive O157
strains caused A/E lesions, the intimin-negative non-O157
strains (including the control strain) formed bacterial layers on
the intestinal mucosal surfaces of CDCD pigs. This observa-
tion suggests that STEC and other E. coli strains that lack
intimin may produce other adhesins that facilitate bacterial
colonization of the large intestine. Such nonintimin adhesins
(like the bundle-forming pili of intimin-positive enteropatho-
genic E. coli strains that promote initial attachment of some
strains to intestinal epithelium) could also be involved in the
adherence of intimin-positive STEC strains. Several putative
nonintimin adhesins have been described, such as long polar
fimbriae (Lpf) and the Vibrio cholerae immunoglobulin A ho-
mologue adhesin (Iha) in STEC O157:H7 (42, 44) and Lpf and
STEC autoagglutinating adhesin (Saa) in non-O157:H7 STEC
(10, 35).
Another difference involved the intensities of vascular le-
sions caused by different types of Stx2. Thus, the vascular
damage in all six pigs inoculated with strain 3024-94 (group C)
was less intense than that in the pigs in the other groups. These
pigs, which were necropsied 42 to 48 h pi, might have devel-
oped more intense lesions if they had been exposed to the toxin
longer. In support of the hypothesis that 3024-94 might have
been as virulent as the other STEC if the pigs had been nec-
ropsied at a later time is the fact that strain 3024-94 has a
longer mean time to death than B2F1 in the streptomycin-
treated mouse model (Melton-Celsa, unpublished observa-
tions).
Although similar vascular alterations were seen in 8 of 16
pigs inoculated with non-O157:H7 strains, including strains
3024-94, B2F1, B2F1 (plasmid cured), and B2F1 Stx2d2-acti-
vatable, these lesions were not seen in the seven animals
inoculated with the B2F1 mutant that produced only Stx2d1-
activatable toxin (group G). The lack of vascular lesions might
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be explained by the fact that B2F1 Stx2d1-activatable pro-
duces lower levels of toxin than the parental strain B2F1 or
B2F1 Stx2d2-activatable produces (11). The hypothesis that
B2F1 produces higher levels of Stx2d2-activatable toxin in vivo,
as well as in vitro, is supported by the observation that B2F1
Stx2d2-activatable is more virulent than B2F1 Stx2d1-activat-
able in both mice (11) and pigs (this study).
In summary, the absence of intimin in non-O157 STEC had
little impact on the overall pathogenesis of systemic disease
during STEC infection of neonatal pigs. The most striking
differences between groups of animals were the presence of
A/E lesions in the pigs inoculated with the intimin-positive
strains and the apparent association between the level of
Stx2d-activatable toxin and the severity of CNS disease and
lesions in pigs inoculated with the intimin-negative non-O157
strains. The most surprising finding in this study was the ubiq-
uity of mucus and crypt lesions observed for all STEC groups,
an observation that suggests that Stx plays a critical role in this
type of intestinal damage. Perhaps the equivalent crypt dam-
age caused by non-O157 strain B2F1 and the O157 strains is a
consequence of a balance of the virulence factors produced by
the two types of STEC strains: the more potent activatable
toxin is made by the less adherent B2F1 strain, while the less
potent toxin is produced by the O157 strains that form the
highly damaging A/E lesions.
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